These effects, together with a earlier report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,two support the notion of focusing on ACKR3 as a singular way to modulate the opioid process, which could open new therapeutic avenues for opioid-associated disorders. Name your selection: Name should https://jessicap627kbq3.blogdun.com/profile